Telitacicept
RC18G002
Phase 3 mab terminated
Quick answer
Telitacicept for Systemic Lupus Erythematosus is a Phase 3 program (mab) at Vor Biopharma with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Vor Biopharma
- Indication
- Systemic Lupus Erythematosus
- Phase
- Phase 3
- Modality
- mab
- Status
- terminated